FR2679138B1 - Compositions pharmaceutiques anti-glaucomateuses et leur procede d'obtention. - Google Patents

Compositions pharmaceutiques anti-glaucomateuses et leur procede d'obtention.

Info

Publication number
FR2679138B1
FR2679138B1 FR9109016A FR9109016A FR2679138B1 FR 2679138 B1 FR2679138 B1 FR 2679138B1 FR 9109016 A FR9109016 A FR 9109016A FR 9109016 A FR9109016 A FR 9109016A FR 2679138 B1 FR2679138 B1 FR 2679138B1
Authority
FR
France
Prior art keywords
pharmaceutical compositions
obtaining same
glaucoma
glaucoma pharmaceutical
obtaining
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9109016A
Other languages
English (en)
Other versions
FR2679138A1 (fr
Inventor
Gerard Schwadrohn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoire Theramex SAM
Original Assignee
Laboratoire Theramex SAM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR9109016A priority Critical patent/FR2679138B1/fr
Application filed by Laboratoire Theramex SAM filed Critical Laboratoire Theramex SAM
Priority to CA002111699A priority patent/CA2111699A1/fr
Priority to JP50077393A priority patent/JP3328729B2/ja
Priority to US08/170,179 priority patent/US5506220A/en
Priority to EP92912769A priority patent/EP0593520B1/fr
Priority to PCT/FR1992/000549 priority patent/WO1992022300A1/fr
Priority to ES92912769T priority patent/ES2139602T3/es
Priority to AT92912769T priority patent/ATE185071T1/de
Priority to DK92912769T priority patent/DK0593520T3/da
Priority to KR1019930703965A priority patent/KR100249555B1/ko
Priority to DE69230069T priority patent/DE69230069T2/de
Priority to IE922252A priority patent/IE922252A1/en
Priority to DZ920090A priority patent/DZ1600A1/fr
Priority to MA22876A priority patent/MA22592A1/fr
Priority to TNSN92063 priority patent/TNSN92063A1/fr
Publication of FR2679138A1 publication Critical patent/FR2679138A1/fr
Application granted granted Critical
Publication of FR2679138B1 publication Critical patent/FR2679138B1/fr
Priority to GR990403060T priority patent/GR3031967T3/el
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR9109016A 1991-06-18 1991-07-17 Compositions pharmaceutiques anti-glaucomateuses et leur procede d'obtention. Expired - Fee Related FR2679138B1 (fr)

Priority Applications (16)

Application Number Priority Date Filing Date Title
FR9109016A FR2679138B1 (fr) 1991-07-17 1991-07-17 Compositions pharmaceutiques anti-glaucomateuses et leur procede d'obtention.
DE69230069T DE69230069T2 (de) 1991-06-18 1992-06-18 Steroide enthaltende zusammensetzungen zur anwendung am auge und ihre verwendung zur behandlung des glaukoms
US08/170,179 US5506220A (en) 1991-06-18 1992-06-18 Anti-glaucomatous pharmaceutical composition and the process for obtaining them
EP92912769A EP0593520B1 (fr) 1991-06-18 1992-06-18 Compositions oculaires contenant des steroides et leur utilisation pour le traitement du glaucome
PCT/FR1992/000549 WO1992022300A1 (fr) 1991-06-18 1992-06-18 Compositions oculaires contenant des steroïdes et leur utilisation pour le traitement du glaucome
ES92912769T ES2139602T3 (es) 1991-06-18 1992-06-18 Composiciones oculares que contienen esteroides y su utilizacion para el tratamiento del glaucoma.
AT92912769T ATE185071T1 (de) 1991-06-18 1992-06-18 Steroide enthaltende zusammensetzungen zur anwendung am auge und ihre verwendung zur behandlung des glaukoms
DK92912769T DK0593520T3 (da) 1991-06-18 1992-06-18 Forbindelser med indhold af steroider og deres anvendelse til behandling af glaucom
CA002111699A CA2111699A1 (fr) 1991-06-18 1992-06-18 Compositions pharmaceutiques anti-glaucomateuses et leur procede d'obtention
JP50077393A JP3328729B2 (ja) 1991-06-18 1992-06-18 抗緑内障薬剤組成物
KR1019930703965A KR100249555B1 (ko) 1991-06-18 1992-06-18 스테로이드를 함유하는 안구용 조성물, 및 녹내장 치료에 이들 조성물을 사용하는 방법
IE922252A IE922252A1 (en) 1991-07-17 1992-07-10 Anti-glaucomatous pharmaceutical compositions and the¹process for obtaining them
DZ920090A DZ1600A1 (fr) 1991-07-17 1992-07-12 Compositions pharmaceutiques anti-glaucomateurses et leur procédé d'obtention.
MA22876A MA22592A1 (fr) 1991-07-17 1992-07-13 Nouveau procede d'obtention d'une composition anti-glaucomateuse et son procede d'obtention .
TNSN92063 TNSN92063A1 (fr) 1991-07-17 1992-07-16 Nouveau procede d'obtention d'une composition anti- glaucomateuse et son procede d'obtention
GR990403060T GR3031967T3 (en) 1991-06-18 1999-11-26 Ocular compositions containing steroids and their use in treating glaucoma

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9109016A FR2679138B1 (fr) 1991-07-17 1991-07-17 Compositions pharmaceutiques anti-glaucomateuses et leur procede d'obtention.

Publications (2)

Publication Number Publication Date
FR2679138A1 FR2679138A1 (fr) 1993-01-22
FR2679138B1 true FR2679138B1 (fr) 1995-03-03

Family

ID=9415212

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9109016A Expired - Fee Related FR2679138B1 (fr) 1991-06-18 1991-07-17 Compositions pharmaceutiques anti-glaucomateuses et leur procede d'obtention.

Country Status (1)

Country Link
FR (1) FR2679138B1 (fr)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2231377B1 (fr) * 1973-05-29 1977-11-04 Barnes Hind Pharm Inc
US4383992A (en) * 1982-02-08 1983-05-17 Lipari John M Water-soluble steroid compounds
JPH07121879B2 (ja) * 1986-11-14 1995-12-25 富士レビオ株式会社 点眼用免疫グロブリン製剤

Also Published As

Publication number Publication date
FR2679138A1 (fr) 1993-01-22

Similar Documents

Publication Publication Date Title
MA22521A1 (fr) Compositions anti- transpirantes en batonnets-gels contenant un derive de la 2-oxazolidinone, et procede pour leur preparation
ITRM910696A0 (it) Composizioni farmaceutiche per l'applicazione per via nasale.
MA26438A1 (fr) Derives 6,5-heterobicycliques substitues, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA26471A1 (fr) Derives d'acide arylsulfonylaminohydroxamique, procede pour leur preparation et compositions pharmaceutiques les contenant.
FR2636628B1 (fr) Derives du thiadiazole-1,3,4, leur procede d'obtention et compositions pharmaceutiques en contenant
MA26519A1 (fr) Derives d'azetidinylpropylpiperidine, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA26552A1 (fr) Derives d'isoquinoleine nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant.
FR2687401B1 (fr) Derives de la 1,4-dialkylpiperazine, procedes d'obtention et compositions pharmaceutiques les contenant.
FR2700956B1 (fr) Composition cosmetique et pharmaceutique et procede pour sa preparation.
FR2682371B1 (fr) Phyllosilicates 2:1 trioctaedriques et leur procede de preparation.
FR2657872B2 (fr) Derive d'amidino-4 chromanne, procede d'obtention et compositions pharmaceutiques le contenant.
MA26437A1 (fr) Derives de trans-piperazine-1-yl-spiro (cyclohexane-1,1'-isobenzofuranne), procede pour leur preparation et compositions pharmaceutiques les contenant.
FR2664814B1 (fr) Compositions pharmaceutiques solides et leur procede de preparation.
FR2615188B1 (fr) Derives d'hydrazine, procede d'obtention et compositions pharmaceutiques les contenant
FR2675144B1 (fr) Nouvelles quinolones difluorees - leur procede de preparation et les compositions pharmaceutiques en renfermant.
FR2706459B1 (fr) Nouveaux dérivés quinoloniques, leur procédé d'obtention et les compositions pharmaceutiques qui en contiennent.
FR2679138B1 (fr) Compositions pharmaceutiques anti-glaucomateuses et leur procede d'obtention.
FR2677250B1 (fr) Compositions pharmaceutiques contenant de l'adenosine-5-triphosphate disodique.
FR2751332B1 (fr) Derives d'oxopyrrolopyrrole, procede pour leur preparation, compositions pharmaceutiques les contenant et leur utilisation
FR2677355B1 (fr) Nouveaux derives de l'oxazole, leur preparation et les compositions pharmaceutiques qui les contiennent.
FR2673944B1 (fr) Derives de l'1,8-naphtalimide, leur procede de preparation et les compositions pharmaceutiques les contenant.
FR2675047B1 (fr) Nouvelles compositions pharmaceutiques anti-glaucomateuses et leur procede d'obtention.
DZ1600A1 (fr) Compositions pharmaceutiques anti-glaucomateurses et leur procédé d'obtention.
FR2677477B1 (fr) Nouveaux derives de l'oxazole leur preparation, leur utilisation et les compositions pharmaceutiques qui les contiennent.
FR2674247B1 (fr) Nouvelles quinolones fluorees, leur procede de preparation et les compositions pharmaceutiques en renfermant.

Legal Events

Date Code Title Description
ST Notification of lapse